12 results
6-K
EX-99.1
BYSI
BeyondSpring Inc
30 Dec 21
Current report (foreign)
12:30pm
to lower clinical development expenses, which were partially offset by higher personnel and non-cash stock-based compensation expenses.
General … September 30, 2020. The $2.3 million decrease was primarily due to lower clinical development expense, partially offset by higher personnel
6-K
EX-99.1
BYSI
BeyondSpring Inc
10 Sep 21
Current report (foreign)
8:30am
-cash stock-based compensation expenses, which were partially offset by lower clinical development expenses.
General and administrative (“G … , regulatory and non-cash stock-based compensation expenses that were partially offset by higher personnel costs.
G&A expenses were $15.4 million
6-K
EX-99.1
BYSI
BeyondSpring Inc
16 Jun 21
BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update
8:36am
to a decrease in clinical trial expenses and non-cash stock-based compensation expense, partially offset by an increase in manufacturing costs
6-K
EX-99.1
88mya49lrm88tcmh314n
10 Jul 19
BeyondSpring Provides Operational Update and First Quarter 2019 Financial Results
11:22am
6-K
EX-99.1
rm4buq1
23 Oct 18
Beyondspring Provides Operational Update and Second-quarter 2018 Financial Results
9:15am
20-F
grdid0chtit6to94x7
28 Apr 17
Annual report (foreign)
12:00am
- Prev
- 1
- Next